BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 6341476)

  • 1. Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines.
    Rhodes AR; Melski JW; Sober AJ; Harrist TJ; Mihm MC; Fitzpatrick TB
    J Invest Dermatol; 1983 May; 80(5):452-9. PubMed ID: 6341476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanosomal alterations in dysplastic melanocytic nevi. A quantitative, ultrastructural investigation.
    Rhodes AR; Seki Y; Fitzpatrick TB; Stern RS
    Cancer; 1988 Jan; 61(2):358-69. PubMed ID: 3334971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.
    Rhodes AR; Harrist TJ; Day CL; Mihm MC; Fitzpatrick TB; Sober AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):563-74. PubMed ID: 6630618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology.
    Rhodes AR; Mihm MC; Weinstock MA
    Mod Pathol; 1989 Jul; 2(4):306-19. PubMed ID: 2762287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
    Hastrup N; Hou-Jensen K
    APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraepidermal distribution patterns of melanocytes in the melanocytic lesions on the sole: proposed criteria for histopathologic diagnosis of plantar malignant melanoma in situ].
    Saida T; Yoshida N
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):553-60. PubMed ID: 2585770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dysplastic melanocytic nevi: quantitative ultrastructural investigation comparing intraepidermal melanocytes of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and normal skin].
    Seki Y; Fitzpatrick TB; Rhodes AR
    Nihon Hifuka Gakkai Zasshi; 1988 Oct; 98(11):1093-103. PubMed ID: 3225938
    [No Abstract]   [Full Text] [Related]  

  • 9. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
    Sagebiel RW
    J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi.
    Piepkorn M
    Arch Dermatol; 1990 Apr; 126(4):514-8. PubMed ID: 2321996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine structural characterization of melanosomes in dysplastic nevi.
    Takahashi H; Horikoshi T; Jimbow K
    Cancer; 1985 Jul; 56(1):111-23. PubMed ID: 4005780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma.
    Aronson PJ; Ito K; Fukaya T; Hashimoto K; Mehregan AH
    J Invest Dermatol; 1988 Apr; 90(4):452-8. PubMed ID: 3280697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidermal melanin unit in the pathophysiology of malignant melanoma.
    Jimbow K; Salopek TG; Dixon WT; Searles GE; Yamada K
    Am J Dermatopathol; 1991 Apr; 13(2):179-88. PubMed ID: 2029092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of clinical and histopathologic features in clinically atypical melanocytic nevi.
    Barnhill RL; Roush GC
    Cancer; 1991 Jun; 67(12):3157-64. PubMed ID: 2044059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
    Roush GC; Barnhill RL
    Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpigmented dysplastic melanocytic nevi.
    Knoell KA; Hendrix JD; Patterson JW; McHargue CA; Wilson BB; Greer KE
    Arch Dermatol; 1997 Aug; 133(8):992-4. PubMed ID: 9267246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histological spectrum of acquired nevi. An analysis of the intraepidermal melanocytic proliferation in common and dysplastic nevi.
    Urso C; Bondi R
    Pathol Res Pract; 1994 Jun; 190(6):609-14. PubMed ID: 7984520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive reactivity of dysplastic melanocytes with a monoclonal antibody against melanoma melanosomes, MoAb HMSA-2.
    Maeda K; Maeda K; Jimbow K
    J Invest Dermatol; 1988 Sep; 91(3):247-50. PubMed ID: 3411143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.